Literature DB >> 26164091

Differential FDG-PET Uptake Patterns in Uninfected and Infected Central Prosthetic Vascular Grafts.

P Berger1, I Vaartjes2, A Scholtens3, F L Moll4, G J De Borst4, B De Keizer3, M L Bots2, J D Blankensteijn5.   

Abstract

OBJECTIVE: (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scanning has been suggested as a means to detect vascular graft infections. However, little is known about the typical FDG uptake patterns associated with synthetic vascular graft implantation. The aim of the present study was to compare uninfected and infected central vascular grafts in terms of various parameters used to interpret PET images.
METHODS: From 2007 through 2013, patients in whom a FDG-PET scan was performed for any indication after open or endovascular central arterial prosthetic reconstruction were identified. Graft infection was defined as the presence of clinical or biochemical signs of graft infection with positive cultures or based on a combination of clinical, biochemical, and imaging parameters (other than PET scan data). All other grafts were deemed uninfected. PET images were analyzed using maximum systemic uptake value (SUVmax), tissue to background ratio (TBR), visual grading scale (VGS), and focality of FDG uptake (focal or homogenous).
RESULTS: Twenty-seven uninfected and 32 infected grafts were identified. Median SUVmax was 3.3 (interquartile range [IQR] 2.0-4.2) for the uninfected grafts and 5.7 for the infected grafts (IQR 2.2-7.8). Mean TBR was 2.0 (IQR 1.4-2.5) and 3.2 (IQR 1.5-3.5), respectively. On VGS, 44% of the uninfected and 72% of the infected grafts were judged as a high probability for infection. Homogenous FDG uptake was noted in 74% of the uninfected and 31% of the infected grafts. Uptake patterns of uninfected and infected grafts showed a large overlap for all parameters.
CONCLUSION: The patterns of FDG uptake for uninfected vascular grafts largely overlap with those of infected vascular grafts. This questions the value of these individual FDG-PET-CT parameters in identifying infected grafts.
Copyright © 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FDG-uptake patterns; PET-scan; Vascular graft infections

Mesh:

Substances:

Year:  2015        PMID: 26164091     DOI: 10.1016/j.ejvs.2015.06.007

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  10 in total

1.  How useful is 18F-FDG PET/CT in patients with suspected vascular graft infection?

Authors:  Jean-François Sarrazin; Mikaël Trottier; Michel Tessier
Journal:  J Nucl Cardiol       Date:  2018-07-25       Impact factor: 5.952

2.  Textural features of 18F-fluorodeoxyglucose positron emission tomography scanning in diagnosing aortic prosthetic graft infection.

Authors:  Ben R Saleem; Roelof J Beukinga; Ronald Boellaard; Andor W J M Glaudemans; Michel M P J Reijnen; Clark J Zeebregts; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-24       Impact factor: 9.236

3.  Diagnostic yield of 18F-FDG PET/CT in suspected diagnosis of vascular graft infection: A prospective cohort study.

Authors:  Hans Bowles; Juan Ambrosioni; Gaspar Mestres; Marta Hernández-Meneses; Nuria Sánchez; Jaime Llopis; Xavier Yugueros; Manel Almela; Asunción Moreno; Vicenç Riambau; David Fuster; Jose M Miró
Journal:  J Nucl Cardiol       Date:  2018-06-15       Impact factor: 5.952

4.  False-positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography in a patient with metallic implants following chondrosarcoma resection.

Authors:  P U Zhou; Jinliang Tang; Dong Zhang; Guanghui Li
Journal:  Mol Clin Oncol       Date:  2016-03-03

Review 5.  Cross-sectional imaging of aortic infections.

Authors:  D J Murphy; A R Keraliya; M D Agrawal; A Aghayev; M L Steigner
Journal:  Insights Imaging       Date:  2016-10-19

6.  Intense 18F-FDG activity in aortoiliac bypass graft mimicking infection: A case report.

Authors:  Minkyung Lee; Jeong Seon Ryu; Chang Hae Suh; In Young Hyun
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

Review 7.  Imaging Modalities for the Diagnosis of Vascular Graft Infections: A Consensus Paper amongst Different Specialists.

Authors:  Chiara Lauri; Roberto Iezz; Michele Rossi; Giovanni Tinelli; Simona Sica; Alberto Signore; Alessandro Posa; Alessandro Tanzilli; Chiara Panzera; Maurizio Taurino; Paola Anna Erba; Yamume Tshomba
Journal:  J Clin Med       Date:  2020-05-17       Impact factor: 4.241

8.  Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.

Authors:  Chiara Lauri; Alberto Signore; Andor W J M Glaudemans; Giorgio Treglia; Olivier Gheysens; Riemer H J A Slart; Roberto Iezzi; Niek H J Prakken; Eike Sebastian Debus; Susanne Honig; Anne Lejay; Nabil Chakfé
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-04       Impact factor: 10.057

9.  Prosthetic vascular graft infection: A systematic review and meta-analysis on diagnostic accuracy of 18FDG PET/CT.

Authors:  Zohre Mahmoodi; Morteza Salarzaei; Mahboobeh Sheikh
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-07-26

Review 10.  State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation.

Authors:  Massimiliano Casali; Chiara Lauri; Corinna Altini; Francesco Bertagna; Gianluca Cassarino; Angelina Cistaro; Anna Paola Erba; Cristina Ferrari; Ciro Gabriele Mainolfi; Andrea Palucci; Napoleone Prandini; Domenico Albano; Luca Burroni; Alberto Cuocolo; Laura Evangelista; Elena Lazzeri; Natale Quartuccio; Brunella Rossi; Giuseppe Rubini; Martina Sollini; Annibale Versari; Alberto Signore; Sergio Baldari; Francesco Bartoli; Mirco Bartolomei; Adriana D'Antonio; Francesco Dondi; Patrizia Gandolfo; Alessia Giordano; Riccardo Laudicella; Michela Massollo; Alberto Nieri; Arnoldo Piccardo; Laura Vendramin; Francesco Muratore; Valentina Lavelli
Journal:  Clin Transl Imaging       Date:  2021-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.